Together, these studies suggest that the Toll pathway may interact with Egr–JNK signalling in regulating cell death during tumour development, yet the modulation mechanisms and a direct role of Toll signalling in cell death have not been documented. The gene discussed is TLR4; the disease is neoplasm.